Ultralife CorporationULBINASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+13.7%
5Y CAGR+11.8%
Year-over-Year Change
Research and development spending
3Y CAGR
+13.7%/yr
vs +12.0%/yr prior
5Y CAGR
+11.8%/yr
Consistent
Acceleration
+1.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $10.40M | +25.8% |
| 2024 | $8.27M | +9.8% |
| 2023 | $7.53M | +6.4% |
| 2022 | $7.08M | +3.7% |
| 2021 | $6.83M | +14.8% |
| 2020 | $5.95M | -12.6% |
| 2019 | $6.80M | +51.0% |
| 2018 | $4.51M | -4.8% |
| 2017 | $4.74M | -20.3% |
| 2016 | $5.95M | - |